-
Gilead says remdesivir coronavirus treatment reduces risk of death in severely sick patients
Gilead Sciences published new data Friday on its antiviral drug remdesivir that shows it reduced the risk of death for severely sick coronavirus patients by 62% compared with standard care alone. The findings are being presented at the Virtual Covid-19 Conference as part of the 23rd International AIDS Conference, the company said. Shares of Gilead rose almost 3% in premarket trading Friday on the news. The company said it collected the data from a comparative analysis using both patients in its phase three trial as well as patients from “a real-world retrospective cohort of patients.” Gilead said its findings ... (full story)
- Comments
- Subscribe
- Comment #1
- Quote
- Jul 10, 2020 9:48am Jul 10, 2020 9:48am
- ww3361
- | Joined Jun 2012 | Status: Member | 709 Comments
- Comment #2
- Quote
- Jul 10, 2020 9:49am Jul 10, 2020 9:49am
- goldenmike
- | Joined Apr 2020 | Status: Member | 89 Comments
- Comment #3
- Quote
- Jul 10, 2020 11:05am Jul 10, 2020 11:05am
- harcos
- | Joined Mar 2020 | Status: Member | 482 Comments